![Mark Rubinstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 258 588 $ per 2026-06-30
Mark L.
Rubinstein is Chief Medical Officer at Achieve Life Sciences, Inc. starting in 2025.
Formerly, Dr. Rubinstein was Head-Medical Affairs at Blip Products, Inc. Education includes a doctorate from Yale University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-28 | 39 600 ( 0,04 % ) | 258 588 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-10-01 |
| Företag | Position | Slut |
|---|---|---|
Blip Products, Inc.
 Blip Products, Inc. Pharmaceuticals: MajorHealth Technology Produces and sells nicotine replacement therapy products through online | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Blip Products, Inc.
Blip Products, Inc. Pharmaceuticals: MajorHealth Technology Produces and sells nicotine replacement therapy products through online | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
